Castle Biosciences Stock In The News
| CSTL Stock | USD 30.44 0.13 0.43% |
Our overall analysis of Castle Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Castle Biosciences. The specific impact of Castle Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Castle Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Castle Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Castle Biosciences Backtesting and Castle Biosciences Hype Analysis. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
Castle |
Castle Biosciences Today Top News and Investor Outlook
Castle Biosciences Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Castle and other traded companies coverage with news coverage. We help investors stay connected with Castle headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Castle Stock performance. Please note that trading solely based on the Castle Biosciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Castle Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Castle earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Castle Biosciences that are available to investors today. That information is available publicly through Castle media outlets and privately through word of mouth or via Castle internal channels. However, regardless of the origin, that massive amount of Castle data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Castle Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Castle Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Castle Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Castle Biosciences alpha.
Castle Largest EPS Surprises
Earnings surprises can significantly impact Castle Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-03-08 | 2020-12-31 | -0.12 | -0.17 | -0.05 | 41 | ||
2021-05-10 | 2021-03-31 | -0.23 | -0.17 | 0.06 | 26 | ||
2021-11-08 | 2021-09-30 | -0.4 | -0.47 | -0.07 | 17 | ||
2022-11-02 | 2022-09-30 | -0.88 | -0.77 | 0.11 | 12 | ||
2020-11-09 | 2020-09-30 | -0.11 | -0.23 | -0.12 | 109 | ||
2024-11-04 | 2024-09-30 | -0.06 | 0.08 | 0.14 | 233 |
Castle Biosciences Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Castle Biosciences Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
26th of November 2024
Castle Biosciences Inc Shares Up 3.52 percent on Nov 26 at gurufocus.com
22nd of November 2024
Castle Biosciences Inc Shares Up 4.5 percent on Nov 22 at gurufocus.com
20th of November 2024
Castle Biosciences to Present at the Piper Sandler 36th Annual Healthcare Conference at finance.yahoo.com
15th of November 2024
Disposition of 800 shares by Frank Stokes of Castle Biosciences at 30.404 subject to Rule ... at gurufocus.com
14th of November 2024
WASATCH ADVISORS LPs Strategic Reduction in Castle Biosciences Inc Holdings at gurufocus.com
12th of November 2024
Disposition of 299 shares by Derek Maetzold of Castle Biosciences at 34.15 subject to Rule... at MacroaxisInsider
8th of November 2024
PBYI Beats Q3 Earnings Revenue Estimates, Revises 24 View, Stock Up at zacks.com
7th of November 2024
Castle Biosciences chief commercial officer sells 124,708 in stock at investing.com
5th of November 2024
Castle Biosciences Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth and ... at finance.yahoo.com
18th of October 2024
AbbVie Secures FDA Approval for Parkinsons Disease Drug Vyalev at zacks.com
2nd of October 2024
Castle Biosciences Hosts Groundbreaking Ceremony at Site of New Corporate Headquarters in ... at businesswire.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Castle Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Castle Biosciences' short interest history, or implied volatility extrapolated from Castle Biosciences options trading.
Check out Castle Biosciences Backtesting and Castle Biosciences Hype Analysis. For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. If investors know Castle will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Castle Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.93) | Earnings Share 0.21 | Revenue Per Share 11.34 | Quarterly Revenue Growth 0.395 | Return On Assets (0) |
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Castle Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Castle Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Castle Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.